Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Multi Bintang Indonesia Tbk. (MLBI) Price & Performance

Indofarma Tbk.Trade
Multi Bintang Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Multi Bintang Indonesia Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Multi Bintang Indonesia Tbk. trades at Rp6,800 (market cap 14.38T, 58.9K 24h volume). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 36.8× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

INAFMLBI
Market Cap
390.51B14.38T
Volume
58.9K
Lot
589
Turnover
400.52M
Average Price
6,799.92
Value
400.52M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
MLBI
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Multi Bintang Indonesia Tbk.

PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).

Read more on MLBI